Clinical Trials Logo

Clinical Trial Summary

Recent clinical studies showed, that a hydrocolloid patch is effective, well tolerated and comparable with aciclovir cream 5 % for the treatment of HSL lesions, while affording additional benefits of wound protection, discretion and relief of social embarrassment. The aim of the actual study was the clinical assessment of the effectiveness and safety of Hansaplast® SOS Herpes Patch (HPHP) in comparison to Compeed® Herpes Vesicle Patch (CHP) in treating HSL. Both products are CE-certificated and are available at the market for medical devices.


Clinical Trial Description

n/a


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT02157090
Study type Interventional
Source Technische Universität Dresden
Contact
Status Completed
Phase N/A
Start date August 2009
Completion date June 2010

See also
  Status Clinical Trial Phase
Completed NCT00809809 - Zinc for the Treatment of Herpes Simplex Labialis (HSL) Phase 3
Recruiting NCT06135844 - Hand Sanitizer Use for Herpes Simplex Virus-1 Early Phase 1